Twenty-five years ago, Donna Rullo participated in a clinical trial involving a relatively unknown, targeted drug for breast cancer. The treatment proved to be life-saving for Rullo and fundamentally altered the standard of care for women diagnosed with the disease in the years that followed. Her involvement in the trial, which took place in the United States, represents a significant milestone in the fight against breast cancer. Rullo's story highlights the critical role clinical trials play in advancing medical treatments and improving patient outcomes. The targeted drug’s success has since benefited countless women facing a breast cancer diagnosis across the United States. Her experience underscores the profound impact one person's decision can have on the broader medical community and future generations of patients. It demonstrates the importance of participation in medical research for continued progress.